ClinicalTrials.Veeva

Menu

Clinical Signs and Activity Limitations Associated With Dural Ectasia in Patients With Marfan Disease (MARFANLOMB)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Marfan Syndrome

Treatments

Other: Questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT05123339
APHP211106
2021-A00654-37 (Other Identifier)

Details and patient eligibility

About

Primary outcome is to compare the frequency and clinical features of spinal symptoms between Marfan patients with dural ectasia (cases) and those without (controls).

  1. / Frequency of orthostatic headaches
  2. / Frequency of low back pain due to orthostasis
  3. / Frequency of low back pain during Vasalva maneuvers
  4. / Frequency of lumbar claudication
  5. / Frequency of root claudication

Secondary outcomes are to compare activity limitations, quality of life and intensity of low back and radicular pain between Marfan patients with dural sac ectasia (cases) and those without (controls).

  1. / Average intensity of back pain measured on a self-administered digital scale (0 = no pain and 100 = maximum pain)
  2. / Average intensity of radicular pain measured on a self-administered digital scale (0 = no pain and 100 = maximum pain)
  3. / Activity limitations specific to the lumbar spine measured using the self-administered Oswestry Disability Index questionnaire (ODI, 0 = no limitations and 100 = maximum limitations)
  4. / Physical component of quality of life measured using the physical component of the self-administered questionnaire 12-Item Short Form Health Survey (SF-12, 9.95 = worst quality of life imaginable, 70.02 = worst quality of life imaginable )
  5. / Mental component of the quality of life measured using the mental component of the SF-12 self-administered questionnaire (5.89 = worst quality of life imaginable, 71.97 = worst quality of life imaginable)

Full description

Marfan's disease is a rare condition. Clinical phenotypes are heterogeneous. Among the abnormalities of the spine, dural ectasia is common with a prevalence of 66%. This is a major sign of Ghent's diagnostic criteria. To our knowledge, the clinical and functional signs associated with dural sac ectasia have never been described with precision. Only a few uncontrolled case series have been published. This is the case of the study by Foran and colleagues published in the American Journal of Genetics in 2005 which included 22 patients with Marfan disease with dural ectasia questioned about their symptoms and quality of life. We hypothesize the existence of a clinical and functional spinal phenotype specific to dural ectasia in patients with Marfan disease.

Enrollment

90 patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Marfan disease according to the Ghent criteria revised in 2010
  • Patients followed at the CNMR in Bichat
  • Adults ≥18 years old and ≤ 55 years old (to limit the incidence of degenerative lumbar pathologies)
  • Patient not opposing the research
  • Mastery of the French language

Exclusion criteria

  • History of lumbar surgery <1 year
  • Specific pathologies of the spine (tumor, infection, trauma, fracture, inflammatory rheumatism)
  • Inability to write, read or speak French
  • Cognitive or behavioral problems making assessment impossible
  • Patients receiving AME
  • Patients under tutorship or curatorship

Trial design

90 participants in 2 patient groups

Case group
Description:
Marfan disease according to Ghent criteria revised in 2010 with dural ectasia Patients followed at the CNMR in Bichat Adults ≥18 years old and ≤ 55 years old (to limit the incidence of degenerative lumbar pathologies) No history of lumbar surgery \<1 year and without specific pathologies of the spine (tumor, infection, trauma, fracture, inflammatory rheumatism)
Treatment:
Other: Questionnaire
Control group
Description:
Marfan disease according to Ghent criteria revised in 2010 without dural ectasia Patients followed at the CNMR in Bichat Adults ≥18 years old and ≤ 55 years old (to limit the incidence of degenerative lumbar pathologies) No history of lumbar surgery \<1 year and without specific pathologies of the spine (tumor, infection, trauma, fracture, inflammatory rheumatism)
Treatment:
Other: Questionnaire

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems